Total Funding
39
Total FundingSeries B raised
Growth Score
pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
DesignMedix develops pharmaceutical drugs designed to address the rapid rise in drug resistance in multiple diseases.
Past Role: HESKA, Founding CEO & Director- David Peyton: CSO
About the Company
DesignMedix develops pharmaceutical drugs designed to address the rapid rise in drug resistance in multiple diseases. Its drugs are developed by covalently linking a chemical moiety derived from a resistance reversal agent in order to fulfill the roles of both therapeutic agent and resistance reversal agent, enabling medical practitioners to treat
malaria and other infectious diseases without a hassle.
Women Founded
Women Led
